12 August 2026
Global law firm Hogan Lovells Cadwalader advises Jazz Pharmaceuticals on acquisition of Actio Biosciences
Advising firms
Deal team
33 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Keith Flaum Lead | Hogan Lovells Cadwalader | Partner | M&A | Silicon Valley |
| Jessica Bisignano Lead | Hogan Lovells Cadwalader | Partner | M&A | Philadelphia |
| Bryan Lowrance Lead | Hogan Lovells Cadwalader | Partner | M&A | Boston |
| Nicola Lemay Lead | Hogan Lovells Cadwalader | Partner | Tax | Boston |
| Michael Frank Lead | Hogan Lovells Cadwalader | Partner | Tax | Silicon Valley |
| Cullen Taylor Lead | Hogan Lovells Cadwalader | Partner | IP | Northern Virginia |
| Kevin Clayton Lead | Hogan Lovells Cadwalader | Partner | Private Equity | Washington, D.C. |
| Lauren Battaglia Lead | Hogan Lovells Cadwalader | Partner | Antitrust and Competition | Washington, D.C. |
| Lee Berner Lead | Hogan Lovells Cadwalader | Partner | Real Estate | Washington, D.C. |
| Tao Leung Lead | Hogan Lovells Cadwalader | Partner | Employment | Los Angeles |
| Sally Gu Lead | Hogan Lovells Cadwalader | Partner | Pharmaceuticals | Washington, D.C. |
| Scott Loughlin Lead | Hogan Lovells Cadwalader | Partner | Data, Privacy and Cybersecurity | Washington, D.C. |
| Scott Reisch Lead | Hogan Lovells Cadwalader | Partner | Environment and Natural Resources | Denver |
| Anne Salladin | Hogan Lovells Cadwalader | Counsel | International Trade | Washington, D.C. |
| Chasse Osborn | Hogan Lovells Cadwalader | Counsel | Tax | Boston |
| Henry Watsky | Hogan Lovells Cadwalader | Counsel | IP | Northern Virginia |
| Ilana Kattan | Hogan Lovells Cadwalader | Counsel | Antitrust and Competition | Washington, D.C. |
| Khaled Mowad | Hogan Lovells Cadwalader | Counsel | Data, Privacy and Cybersecurity | New York |
| Matthew Miller | Hogan Lovells Cadwalader | Counsel | Environment and Natural Resources | Denver |
| Spenser Karr | Hogan Lovells Cadwalader | Senior associate | M&A | Philadelphia |
| Bothwell Graham | Hogan Lovells Cadwalader | Senior associate | Tax | Washington, D.C. |
| Benjamin Kim | Hogan Lovells Cadwalader | Senior associate | IP | Northern Virginia |
| Regina Mendoza | Hogan Lovells Cadwalader | Senior associate | Private Equity | San Francisco |
| Eman Al-Hassan | Hogan Lovells Cadwalader | Senior associate | Pharmaceuticals | Los Angeles |
| Zach Alvarez | Hogan Lovells Cadwalader | Senior associate | International Trade | Washington, D.C. |
| Isolte Beal | Hogan Lovells Cadwalader | Associate | M&A | Silicon Valley |
| Mandy Zhang | Hogan Lovells Cadwalader | Associate | M&A | Silicon Valley |
| Amy Isselmann | Hogan Lovells Cadwalader | Associate | M&A | Philadelphia |
| Mallorie Ross | Hogan Lovells Cadwalader | Associate | IP | Northern Virginia |
| Laura Penaranda | Hogan Lovells Cadwalader | Associate | Employment | Los Angeles |
| Carter Bowman | Hogan Lovells Cadwalader | Associate | Antitrust and Competition | Not stated |
| Ellen Jin | Hogan Lovells Cadwalader | Associate | Global Regulatory and IP | Washington, D.C. |
| Austin McCleery | Hogan Lovells Cadwalader | Associate | Environment and Natural Resources | Denver |
30 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 820m (US$820 million upfront)
- What the figure measures
- Total transaction value
- Client
- Jazz Pharmaceuticals plcBuy-side
- Counterparties
- Actio Biosciences, Inc. (Sell-side)